Tin tức & Cập nhật
Xem bài viết Khớp
Xem
Chỉ hiển thị Multimedia

Biologic DMARDs offer clinical benefits in adult-onset Still disease
15 May 2024
bởiStephen Padilla
Use of biologic disease-modifying antirheumatic drugs (bDMARDs), particularly tocilizumab (TCZ), anakinra (ANK), and canakinumab (CNK), appears safe and effective in the treatment of adult-onset Still disease (AOSD), results of a systematic review and meta-analysis have shown.
15 May 2024

Perceptions of SLE flare differ between patients, physicians
15 May 2024
Patients differ from physicians regarding their views of systemic lupus erythematosus (SLE) flares, a study has found. The former see flares as days of having fatigue, pain, and skin issues, while the latter define flares as periods of elevated clinical SLE activity.
15 May 2024






